Opioid receptor types selectively cointernalize with G protein-coupled receptor kinases 2 and 3

被引:31
作者
Schulz, R [1 ]
Wehmeyer, A [1 ]
Schulz, K [1 ]
机构
[1] Univ Munich, Inst Pharmacol Toxicol & Pharm, D-80539 Munich, Germany
关键词
D O I
10.1124/jpet.300.2.376
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Activation of G protein-coupled receptors (GPCRs) may bring about their disappearance from the cell membrane, and it is commonly accepted that G protein-coupled receptor kinases (GRKs) play a key function in this mechanism. Opioid receptors belong to the family of GPCRs and are substrates of GRKs. We examined the fate of delta- and mu-opioid receptors and GRK2 and 3 in living cells during the process of receptor sequestration, using laser scanning microscopy. For visualization purposes, receptors and kinases were tagged at their respective C terminus with a fluorophore. The opioid receptors were fused to enhanced green fluorescence protein (EGFP), and the GRKs were linked to red fluorescence protein (DsRed). The cDNAs of these constructs served for transfection of human embryonic kidney 293 cells and neuroblastoma-glioma hybrid cells (NG 108-15), respectively. We report that activation of delta-opioid-EGFP receptors triggers a rapid translocation of cytosolic GRK-DsRed toward the cell membrane, which in turn releases vesicles carrying both green fluorescent delta-receptors and red fluorescent GRKs. Phosducin, a Gbetagamma scavenger, completely prevents translocation of GRKs and the formation of vesicles. In analogous experiments with g-opioid receptors fused to EGFP, we observed that receptor activation also discharges green fluorescent vesicles. In contrast to delta-receptors, mu-receptors failed to trigger accumulation of GRK2 or 3 at the membrane, and no cointernalization of mu-opioid receptors with GRK2 or 3 was observed. The results suggest that delta-opioid receptors, but not g-receptors, cointernalize with GRK2 or 3.
引用
收藏
页码:376 / 384
页数:9
相关论文
共 36 条
[21]   G protein-coupled receptor kinases [J].
Pitcher, JA ;
Freedman, NJ ;
Lefkowitz, RJ .
ANNUAL REVIEW OF BIOCHEMISTRY, 1998, 67 :653-692
[22]   Kinase-inactive G-protein-coupled receptor kinases ave able to attenuate follicle-stimulating hormone-induced signaling [J].
Reiter, E ;
Marion, S ;
Robert, F ;
Troispoux, C ;
Boulay, F ;
Guillou, F ;
Crepieux, P .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2001, 282 (01) :71-78
[23]  
Roettger BF, 1997, MOL PHARMACOL, V51, P357
[24]  
RuizGomez A, 1997, J BIOL CHEM, V272, P9601
[25]   Rat beta-adrenergic receptor kinases 1 and 2 in mouse neuroblastoma X rat glioma NG 108-15 hybrid cells [J].
Schulz, K ;
Muller, S ;
BelkeLouis, G ;
Schulz, R .
BIOCHEMICAL PHARMACOLOGY, 1998, 55 (01) :65-70
[26]  
Schulz R, 1999, J PHARMACOL EXP THER, V289, P599
[27]   Phosducin, β-arrestin and opioid receptor migration [J].
Schulz, R ;
Wehmeyer, A ;
Murphy, J ;
Schulz, K .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1999, 375 (1-3) :349-357
[28]   Translocation of phosducin in living neuroblastoma x glioma hybrid cells (NG 108-15) monitored by red-shifted green fluorescent protein [J].
Schulz, R ;
Schulz, K ;
Wehmeyer, A ;
Murphy, J .
BRAIN RESEARCH, 1998, 790 (1-2) :347-356
[29]   The pharmacology of phosducin [J].
Schulz, R .
PHARMACOLOGICAL RESEARCH, 2001, 43 (01) :1-10
[30]   Regulation of G protein-coupled receptors by receptor kinases and arrestins [J].
SterneMarr, R ;
Benovic, JL .
VITAMINS AND HORMONES - ADVANCES IN RESEARCH AND APPLICATIONS, VOL 51, 1995, 51 :193-234